AU Patent

AU2001285489A1 — 5-ASA derivatives having anti-inflammatory and antibiotic activity and methods of treating diseases therewith

Assigned to Nobex Corp · Expires 2002-03-13 · 24y expired

What this patent protects

Compounds are disclosed represented by the following formula:where R1 is a substituted or unsubstituted phenyl group, and where Z is selected such that a compound, Z-R1-NH2, formed by cleavage of the azo bond is a non-absorbable antibiotic; or an ester or pharmacologically accept…

USPTO Abstract

Compounds are disclosed represented by the following formula:where R1 is a substituted or unsubstituted phenyl group, and where Z is selected such that a compound, Z-R1-NH2, formed by cleavage of the azo bond is a non-absorbable antibiotic; or an ester or pharmacologically acceptable salt of the compound of Formula I. Compounds of the present invention may be utilized for the prophylaxis or treatment of various diseases including, but not limited to, intestinal diseases such as inflammatory bowel disease and/or traveler's diarrhea, liver diseases such as hepatic encephalopathy, and/or diseases treatable by a non-absorbable antibiotic.

Drugs covered by this patent

Patent Metadata

Patent number
AU2001285489A1
Jurisdiction
AU
Classification
Expires
2002-03-13
Drug substance claim
No
Drug product claim
No
Assignee
Nobex Corp
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.